NCT05092516Active, not recruiting
Home-based Brain Stimulation Treatment for Post-acute Sequelae of COVID-19 (PASC)
Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Cognitive Post-acute Sequelae of COVID-19 (PASC)
Source: ClinicalTrials.gov · Last updated 21 Oct 2026
Brief summary (registry, in English)
The main goal of this study is to improve dysexecutive symptoms (e.g., sustained attention, processing speed) in patients exhibiting post-acute sequelae of COVID-19 (PASC) through home-based transcranial direct current stimulation (tDCS), a noninvasive method that uses low intensity electric currents delivered to the brain through stimulation electrodes on the scalp.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 31 (actual)
- First submitted
- 21 Oct 2021
- Start date
- 7 Jun 2022
- Primary completion date
- 13 Mar 2025
- Lead sponsor
- Massachusetts General Hospital
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT05092516
What you commit to
- Study type: Interventional
- Participants enrolled: 31
- From 7 Jun 2022 to the primary completion date, 13 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Metallic implants in the head and neck,
Other illness
- History of epilepsy
- Premorbid major neurological illness
- Severe mental illness (e.g., bipolar disorder, schizophrenia)
- Attention Deficit Hyperactivity Disorder
Other
- Brain stimulators
- Pacemakers
- Pregnancy
- Active substance dependence (except for tobacco)
Who the study is looking for
- Ability to provide informed consent
- A diagnosis of PASC as indicated by past COVID-19 infection, and persistent symptoms, including 'brain fog', confusion, short-term memory deficits, trouble concentrating, delirium, difficulties in multitasking.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Massachusetts General Hospital Coordinator of this site? Confirm its status | Charlestown | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.